EX-16 2 ea143230ex-16_neuroone.htm LETTER FROM BDO USA, LLP

 

Exhibit 16

 

June 24, 2021

 

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

 

We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred on June 18, 2021, to be filed by our former client, NeuroOne Medical Technologies Corporation. We agree with the statements made in response to that Item insofar as they relate to our Firm.

 

Very truly yours,

 

/s/ BDO USA, LLP